SCHEMBL21514178

SCHEMBL21514178

COCCOc1ncc2nc(C)nc(Cl)c2n1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.38
▸ PLAU P00749 1/20 0.35
▸ TLR7 Q9NYK1 7/20 0.35
▸ KRAS P01116 1/20 0.34
▸ SOS1 Q07889 1/20 0.34
▸ CYP1A2 P05177 9/20 0.33
▸ CYP3A4 P08684 8/20 0.33
▸ ALDH1A1 P00352 6/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP2C19 P33261 4/20 0.32
▸ USP2 O75604 3/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ CYP2C9 P11712 2/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ PIN1 Q13526 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29882178 1.00 TSHR (0.38) TSHRPLAUTLR7KRASSOS1
SCHEMBL29882295 0.83 KRAS (0.34) KRASSOS1CYP1A2ALDH1A1USP2
SCHEMBL21514180 0.83 KRAS (0.34) KRASSOS1CYP1A2ALDH1A1USP2
SCHEMBL21514130 0.83 CYP1A2 (0.42) TSHRCYP1A2CYP3A4ALDH1A1MAPK1
SCHEMBL29882809 0.83 CYP1A2 (0.42) TSHRCYP1A2CYP3A4ALDH1A1MAPK1
SCHEMBL21514306 0.77 CYP1A2 (0.52) TSHRCYP1A2CYP3A4ALDH1A1MAPK1
SCHEMBL29883025 0.73 ALDH1A1 (0.50) TSHRCYP1A2CYP3A4ALDH1A1MAPK1
SCHEMBL21514670 0.73 ALDH1A1 (0.50) TSHRCYP1A2CYP3A4ALDH1A1MAPK1
SCHEMBL21514305 0.71 TRPV1 (0.41) TSHRTLR7CYP1A2CYP3A4ALDH1A1
SCHEMBL12393233 0.67 TSHR (0.35) TSHRPLAUTLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019201848-A1 2-METHYL-AZA-QUINAZOLINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-10-24 — — WO disclosed
Send feedback